Biotechnology company focused on extraction and standardization of quality controlled psychoactive compounds from plants and fungi HAVN Life Sciences Inc. (CSE:HAVN) (OTCMKTS: HAVLF) announced having harvested its first crop containing psilocybin mushrooms from its growing and production facility in Jamaica.
The company says it will be exporting the psilocybin it harvested to Canada for it to be tested for safety and quality control through its lab partner Delic Labs. The company is working on this project of harvesting psilocybin mushroom in Jamaica with GMP manufacturer P.A. Benjamin in Kingston as its partner.
“This is the moment we have been tirelessly working towards. We’ve been aggressively meeting the targets in our strategic roadmap and having this last piece in place with DELIC Labs will enable HAVN Life to become the first and top choice for product supply globally,” said HAVN’s CEO, Tim Moore.
On the other side, Delic Labs expressed how delighted it is to work with HAVN Life on this projet particularly testing psilocybin mushrooms which are considered exciting and challenging with major medical potential.
“Delic Labs is delighted to partner with HAVN on some of the world’s first psilocybin mushroom testing. Our lab has significantly built out its analytical and research capabilities to offer quality and safety testing to the psychedelic industry,” said the company’s CEO, Dr. Markus Roggen.
